Title: Mei-Chang Kuo: Innovator in Insulin Formulations
Introduction
Mei-Chang Kuo is a notable inventor based in the United States, recognized for her contributions to the field of insulin formulations. With a focus on creating innovative solutions for diabetes management, she has developed formulations that aim to improve the delivery and stability of insulin.
Latest Patents
Mei-Chang Kuo holds patents for groundbreaking inventions, including "Liquid Insulin Formulations And Methods Relating Thereto." This patent describes liquid formulations of insulin that are both physically and chemically stable, while notably being free of preservatives or stabilizers. These formulations are designed for various modes of delivery, including pulmonary delivery. Another significant patent is "Preservative Free Insulin Formulations And Systems And Methods For Aerosolizing." This invention details an insulin formulation specifically adapted for aerosolization, comprising a major amount of water and a minor amount of insulin, while being free of preservatives such as meta-cresol, cresol, or phenol.
Career Highlights
Throughout her career, Mei-Chang Kuo has worked with several companies, including Dance Pharmaceuticals, Inc. and Savara Inc. Her work has significantly impacted the development of insulin delivery systems, showcasing her commitment to advancing diabetes care.
Collaborations
Mei-Chang Kuo has collaborated with notable individuals in her field, including John S. Patton and Ryan S. Patton. These collaborations have contributed to her innovative work in insulin formulations.
Conclusion
Mei-Chang Kuo's contributions to insulin formulations reflect her dedication to improving diabetes management through innovative solutions. Her patents and career achievements highlight her role as a significant inventor in the field.